- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech High Growth Potential Companies
Swedish Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Feb 03, 2023
Companies with a Future performance score of at least 3, ordered by Future performance score.
28 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CALTXCalliditas Therapeutics | kr97.10 | -2.7% | 1.3% | kr5.8b | kr246.80 | PS14.3x | E51.4% | n/a | ||
| CAMXCamurus | kr248.40 | -3.0% | 88.5% | kr13.8b | kr310.00 | PE483.6x | E42.5% | n/a | ||
| GENOGenovis AB (publ.) | kr63.00 | 9.2% | 9.6% | kr4.1b | kr76.00 | PE100.8x | E83.5% | n/a | ||
| XBRANEXbrane Biopharma | kr101.60 | 0.4% | 11.0% | kr2.8b | kr224.00 | PS96x | E98.5% | n/a | ||
| EGTXEgetis Therapeutics | kr6.17 | -1.3% | 4.9% | kr1.5b | kr15.67 | PS76.5x | E77.2% | n/a | ||
| BIOA BBioArctic | kr297.40 | -6.9% | 166.0% | kr26.2b | kr367.80 | PE944.7x | E79.0% | 0% | ||
| BINVBioInvent International | kr32.00 | -5.7% | -15.4% | kr2.1b | kr113.00 | PS6.8x | E64.4% | n/a | ||
| IVACCIntervacc | kr21.72 | -6.0% | -56.9% | kr1.1b | kr97.00 | PS105.1x | E90.5% | n/a | ||
| XSPRAYXspray Pharma | kr63.80 | 1.3% | 2.9% | kr1.4b | n/a | PB2.8x | E124.4% | n/a | ||
| INITInitiator Pharma | kr6.08 | -6.2% | -31.2% | kr318.4m | kr14.26 | PB5.6x | E24.7% | n/a | ||
| SCOLScandion Oncology | kr2.87 | 1.4% | -82.7% | kr116.8m | kr3.90 | PB0.9x | E67.3% | n/a | ||
| KANKancera | kr3.55 | 8.4% | -42.7% | kr282.3m | kr5.50 | PB3.4x | E74.3% | n/a | ||
| CLBIOCorline Biomedical | kr9.00 | -3.4% | -28.6% | kr193.4m | kr32.00 | PE276.3x | E156.8% | n/a | ||
| ATORXAlligator Bioscience | kr2.06 | 10.6% | -17.6% | kr455.3m | kr3.97 | PS21.2x | E77.6% | n/a | ||
| IMMUMendus | kr2.42 | -12.0% | -23.5% | kr482.6m | kr6.50 | PS268x | E62.4% | n/a | ||
| GEANGenetic Analysis | kr2.33 | 3.8% | -57.7% | kr57.9m | kr3.50 | PS2.6x | E59.8% | n/a | ||
| ORXOrexo | kr18.26 | 2.9% | -20.6% | kr627.6m | kr37.67 | PS1x | E100.6% | n/a | ||
| VITRVitrolife | kr255.80 | 10.4% | -33.6% | kr34.6b | kr335.00 | PE87.9x | E26.4% | 0.3% | ||
| CANTACantargia | kr5.53 | -17.7% | -71.1% | kr923.4m | kr22.00 | PB1.9x | E89.5% | n/a | ||
| SECARESwedencare | kr36.67 | 5.5% | -65.3% | kr5.8b | kr54.75 | PE39.6x | E31.8% | 0.5% | ||
| SPRINTSprint Bioscience | kr0.70 | -4.4% | -84.4% | kr49.0m | kr3.30 | PS61x | S79.2% | n/a | ||
| FLUOFluoGuide | kr58.70 | 1.0% | -27.4% | kr692.7m | kr119.57 | PB10.8x | E70.9% | n/a | ||
| PROBProbi | kr178.80 | -0.1% | -53.3% | kr2.0b | n/a | PE50.2x | E20.5% | 0.7% | ||
| ACTIActive Biotech | kr1.00 | 6.7% | -12.0% | kr264.9m | kr2.80 | PB5.4x | E98.1% | n/a |